Governance

Executive Committee

André Choulika, PhD, Chairman and Chief Executive Officer
Julia Berretta, PhD, VP Business Development and Strategic Planning
Philippe Duchateau, PhD, Chief Scientific Officer
Eric Dutang, Chief Financial Officer
Mathieu Simon, MD, Executive Vice President, Chief Operating Officer
David Sourdive, PhD, Executive Vice President Technical Operations
Marie-Bleuenn Terrier, General Counsel

View biographies

Board of Directors

André Choulika, PhD, Chairman of the Board of Directors and CEO
Laurent Arthaud, Independent Director
Pierre Bastid, Independent Director
Alain Godard, Independent Director
Jean-Marie Messier, Independent Director
Annick Schwebig, Independent Director
Mathieu Simon, MD, Director, Executive Vice-President, Chief Operating Officer
David Sourdive, PhD, Director, Executive Vice President Technical Operations

View biographies

Clinical Advisory Board

Pr John Gribben, Lead of the Centre for Hemato-Oncology, Barts Cancer Institute of London, UK
Pr Kanti Rai, Professor of Medicine and Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, USA
Pr Catherine Thieblemont, Professor of Hematology in the Paris VII- University, France and Head of the Hemato-Oncology Unit of St-Louis Hospital in Paris
Pr Koen van Besien, Director of the Stem Cell Transplant Program and Professor of Medicine at Weill Cornell Medical College, NYC, USA

View biographies

Committees of the Board of Directors

Audit and Finance committee
Laurent Arthaud, Independent Director
Pierre Bastid, Independent Director

Compensation committee
Alain Godard, Independent Director
Annick Schwebig, Independent Director

External Auditors

Statutory Auditor
Ernst & Young JMH Conseils

Alternate Auditor
Georges Ray Conseils Auditex

 

Independent Directors according to Nasdaq rules